Back to Search Start Over

GRADE guidelines: 9. Rating up the quality of evidence

Authors :
Guyatt, Gordon H.
Oxman, Andrew D.
Sultan, Shahnaz
Glasziou, Paul
Akl, Elie A.
Alonso-Coello, Pablo
Atkins, David
Kunz, Regina
Brozek, Jan
Montori, Victor
Jaeschke, Roman
Rind, David
Dahm, Philipp
Meerpohl, Joerg
Vist, Gunn
Berliner, Elise
Norris, Susan
Falck-Ytter, Yngve
Murad, M. Hassan
Schünemann, Holger J.
Source :
Journal of Clinical Epidemiology. Dec2011, Vol. 64 Issue 12, p1311-1316. 6p.
Publication Year :
2011

Abstract

Abstract: The most common reason for rating up the quality of evidence is a large effect. GRADE suggests considering rating up quality of evidence one level when methodologically rigorous observational studies show at least a two-fold reduction or increase in risk, and rating up two levels for at least a five-fold reduction or increase in risk. Systematic review authors and guideline developers may also consider rating up quality of evidence when a dose–response gradient is present, and when all plausible confounders or biases would decrease an apparent treatment effect, or would create a spurious effect when results suggest no effect. Other considerations include the rapidity of the response, the underlying trajectory of the condition, and indirect evidence. [Copyright &y& Elsevier]

Details

Language :
English
ISSN :
08954356
Volume :
64
Issue :
12
Database :
Academic Search Index
Journal :
Journal of Clinical Epidemiology
Publication Type :
Academic Journal
Accession number :
66945059
Full Text :
https://doi.org/10.1016/j.jclinepi.2011.06.004